<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for MDCO</title>
    <link />
    <description>Headlines for The Medicines Company</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/13/05/3599029/top-4-small-cap-stocks-in-the-drug-manufacturers-other-industry-with-the.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 17 May 2013 04:35:12 GMT</pubDate>
    </item>
    <item>
      <title>Why The Medicines Company May Be About to Take Off</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/16/why-the-medicines-company-may-be-about-to-take-off/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 16 May 2013 01:02:12 GMT</pubDate>
    </item>
    <item>
      <title>The Medicines Company CEO Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Tra</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1438211-the-medicines-company-ceo-presents-at-bank-of-america-merrill-lynch-2013-health-care-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 17:12:04 GMT</pubDate>
    </item>
    <item>
      <title>Pediatric Approval for MDCO/BMY's Recothrom - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99488/pediatric-approval-for-mdco-bmys-recothrom.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 15 May 2013 16:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Highs</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3579441/stocks-hitting-52-week-highs.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 10 May 2013 11:12:45 GMT</pubDate>
    </item>
    <item>
      <title>Predicting Biotech Stock Moves Using Top Consensus Picks By Legendary Fund Managers</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1403711-predicting-biotech-stock-moves-using-top-consensus-picks-by-legendary-fund-managers.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 05 May 2013 13:23:34 GMT</pubDate>
    </item>
    <item>
      <title>Earnings Increase at The Medicines Co. - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98088/earnings-increase-at-the-medicines-co.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 26 Apr 2013 16:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Chuck Royce Buys Stifel Financial, Tidewater, Alamos, Sells Kennametal, Gardner Denver, Gartner</title>
      <link>http://www.fool.com/news/xt/gurufocus/www.gurufocus.com/news/217406/chuck-royce-buys-stifel-financial-tidewater-alamos-sells-kennametal-gardner-denver-gartner.aspx?source=itxwebtxt0000015</link>
      <author>GuruFocus</author>
      <pubDate>Thu, 25 Apr 2013 12:36:22 GMT</pubDate>
    </item>
    <item>
      <title>The Medicines Company's CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1367831-the-medicines-company-s-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 24 Apr 2013 16:22:06 GMT</pubDate>
    </item>
    <item>
      <title>Trius: Topline Data From Second Phase III Trial Of Tedizolid Is Imminent</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1282511-trius-topline-data-from-second-phase-iii-trial-of-tedizolid-is-imminent.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 18 Mar 2013 08:54:37 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Credit Suisse Initiates The Medicines Company at Outperform on Pipeline Catalysts</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3419811/update-credit-suisse-initiates-the-medicines-company-at-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 15 Mar 2013 08:44:42 GMT</pubDate>
    </item>
    <item>
      <title>Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/13/03/3407211/top-4-nasdaq-stocks-in-the-drug-manufacturers-other-industry-with-the-hi.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 12 Mar 2013 04:40:40 GMT</pubDate>
    </item>
    <item>
      <title>MDCO's Cangrelor Impresses - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94495/mdcos-cangrelor-impresses.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 11 Mar 2013 18:06:01 GMT</pubDate>
    </item>
    <item>
      <title>The Medicines Company's CEO Discusses Phase 3 Cangrelor CHAMPION PHOENIX Trial Results and Outlook (</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1264391-the-medicines-company-s-ceo-discusses-phase-3-cangrelor-champion-phoenix-trial-results-and-outlook-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 11 Mar 2013 17:03:07 GMT</pubDate>
    </item>
    <item>
      <title>4 Big Stocks Rising on Big Volume</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/4-big-stocks-rising-big-volume.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 11 Mar 2013 14:20:00 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Bank of America Raises PT on The Medicines Company on Higher Cangrelor Expectations</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3404404/update-bank-of-america-raises-pt-on-the-medicines-compan.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 11 Mar 2013 10:15:45 GMT</pubDate>
    </item>
    <item>
      <title>Don't Get Too Worked Up Over The Medicines Company's Latest Numbers</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/08/dont-get-too-worked-up-over-the-medicines-company/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 08 Mar 2013 01:04:10 GMT</pubDate>
    </item>
    <item>
      <title>Encouraging News for Cubist Pharma - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/93851/encouraging-news-for-cubist-pharma.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 01 Mar 2013 17:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Waiting Out a Stock Correction</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/waiting-out-a-stock-correction-cm222635.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Fri, 01 Mar 2013 14:29:00 GMT</pubDate>
    </item>
    <item>
      <title>Time, Money and Growth Investing</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/time-money-and-growth-investing-cm220398.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Fri, 22 Feb 2013 14:22:00 GMT</pubDate>
    </item>
  </channel>
</rss>
